PlainPharmaWatch

CMS Open Payments · Program Year 2024

California

California received $342,387,418.09 in pharmaceutical-industry payments to 75,013 physicians and 121 teaching hospitals across 1,410,893 transactions.

$342.4M
Total payments
$289.3M
To physicians
$33.6M
To teaching hospitals
#1
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $342.4M in payments to 75,013 physicians and 121 teaching hospitals in California. That ranks California #1 of 59 states and territories (2.5% of the US total), averaging $3.9K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

California pairs top-1% payment volume with a physician-heavy payment mix.

#1
of 59 states
2.5%
of the national total
84.5%
to physicians vs. hospitals
75,013
physicians paid

What the Data Shows for California

California sits in the high-volume tercile at #1 of 59 by all-tracks dollars (2.5% of the US total): $342,387,418.09 across 1,410,893 PY2024 transactions.

Physician versus hospital mix is near the corpus middle (84.5% / 9.8%). Average transaction $242.67. Leading nature of payment: "Compensation for Services Other Than Consulting" at $85.6M (25.0% of the state file; top-three natures 66.1%).

California sits in the 100th percentile (top-10 nationally). Just below: Florida ($334.6M). For context: top-ranked California ($342.4M) is 1.0× larger than California. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in California are distributed between physicians and teaching hospitals.

Physician Payments

$289.3M

84.5% of total · 75,013 recipients · $3.9K avg

Teaching Hospital Payments

$33.6M

9.8% of total · 121 hospitals · $277.9K avg

Payment Breakdown by Type

California has 16 types of pharmaceutical payments. "Compensation for Services Other Than Consulting" accounts for 25.0%.

Nature concentration in California

Top three Open Payments natures are 66.1% of state dollars; residual is every other reported nature

Compensation for Services Ot…$85.6MConsulting Fee$72.5MRoyalty or License$68.0MAll other natures (13)$116.2M

Payment categories in California

Top categories by total reported dollar volume

1. Compensation for Services…$85.6M2. Consulting Fee$72.5M3. Royalty or License$68.0M4. Food and Beverage$41.6M5. Travel and Lodging$23.9M6. Grant$15.7M7. Education$7.3M8. Honoraria$6.0M9. Space Rental or Facility …$4.7M10. Compensation for Faculty…$4.7M
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $85.6M 27,034
Consulting Fee $72.5M 21,560
Royalty or License $68.0M 2,214
Food and Beverage $41.6M 1,262,821
Travel and Lodging $23.9M 65,363
Grant $15.7M 1,010
Education $7.3M 18,260
Honoraria $6.0M 1,920
Space Rental or Facility Fees $4.7M 924
Compensation for Faculty or Speaker (Medical Education) $4.7M 1,688
Acquisitions $4.6M 81
Long-Term Medical Supply or Device Loan $4.2M 2,227
Debt Forgiveness $2.7M 732
Gift $701.3K 4,075
Charitable Contribution $163.0K 60
Entertainment $79.7K 924

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What California totals can and cannot tell you

The aggregate payment figure for California measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download California's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.